1999, Number 6
<< Back Next >>
Rev Mex Pediatr 1999; 66 (6)
Factor de transferencia bovino en el choque séptico neonatal
Rodríguez BI, Pérez MPY, Jiménez GGA, Castañeda VMA, Rodríguez RV, Rodríguez BR, Rodríguez de TC
Language: Spanish
References: 20
Page: 240-245
PDF size: 128.51 Kb.
ABSTRACT
Objective. Use of intravenous immunoglobulin together with the factor to stimulate colonies of granulocytes and the transfer factor to rescue newborn with septic shock.
Material and methods. Ten newborn with diagnosis of septic shock and with no response after general management; a positive hemocultive and management before the use of intravenous immunoglubulin and the factor to stimulate colonies of granulocytes, received a lyophilized transfer factor extracted from bovine thymus it was used daily at a dosage of one half of a unit for ten days.
Results. Most of the newborn wighed less than 1250 g
(7/10), and they were diagnosed with hyalin membrane disease, a low Apgar and they were hypotrophic (6/10). We observed an increase in leukocytes (8/10) and platelets (8/19). 100% of the newborns treated survived septic shock.
Conclusion. The use of the transfer factor in rescuing infants from septic shock whenever immunotherapy
alternatives have been used such as intravenous immunoglobulin and the factor for stimulating granulocyte colonies.
REFERENCES
Remington JS, Klein JO. Infectious disease of the fetus and newborn infant. 4a ed. Philadelphia: WB Saunders company, 1995; 835-890.
Mancilla-Ramírez J. Choque séptico en neonatos. Bol Med Hosp Infant Mex 1992; 49: 766-76.
Mancilla-Ramírez J, Arredondo-García JL. Avances y promesas en la inmunoterapia de sepsis neonatal. Bol Med Hosp Infant Mex 1999; 56: 109-120.
González-Saldaña N, Saltigerial SP, Macías PM. Infectología Neonatal. 1a. ed. México, D. F: Editorial Trillas SA de CV 1997: 29-45.
Mancilla-Ramírez J. Ruptura prematura de membranas y parto pretérmino. I. Mediadores inflamatorios en la ruptura prematura de membranas. Gac Med Mex 1998; 134: 423-426.
Mancilla-Ramírez J, Sánchez-Saucedo LU. Septicemia neonatal: diferencias entre recién nacidos a término y de pretérmino. Bol Med Hosp Infant Mex 1990; 47: 230-233.
Rodríguez-Balderrama I, Rodríguez-Tamez A, Torres-Bernal JT y col. Utilización de los catéteres percutáneos en neonatología: colocación de 105 catéteres. Bol Med Hosp Infant Mex 1993; 50: 162166.
Pérez-Delgadillo MA, Cashat-Cruz M, Ávila-Figueroa C. Infecciones relacionadas a catéteres intravasculares. Bol Med Hosp Infant Mex 1998; 55: 341-347.
Lynn WA, Vohen J. Adjunt therapy for septic skock: A review of experimental approaches. Clin Infect Dis 1995; 20: 143-158.
Yancey MK, Duff P, Kubilis P et al. Risk factors for neonatal sepsis. Obstet Gynecol 1996; 87: 188-194.
Weisman L, Cruess D, Fischer G. Standard versus hyperimmune intravenous immunoglobulin preventing or treating neonatal bacterial infections. Clin Perinatol 1993; 20: 211-224.
Nankervis C, Seguin J. Granulocyte colony-stimulating factor for neutropenia in neonatal sepsis. Arch Pediatr Adolesc Med 1995; 149: 218-219.
Ashkenazi A, Chamow S. Immunoadhesins as research tools and therapeutic agents. Curr Opin Immunol 1997; 9: 195-200.
Alvarez-Thull, Kirkpatrick CH. Profiles of cytokine in recipients of tranfer factors. Bioterapy 1996: 9(1-3): 55-59.
Pizza G, De Vinci C, Fornarola V et al. In vitro studies during long-term oral administration of specific transfer factor. Bioterapy 1996: 9: 175-85.
Kirkpatrick CH. Activities and characteristics of transfer factors. Bioterapy 1996; 9: 13-16.
Barnet K, Vacek A, Cech K, Pekarek J. The effect of DLE fractions on GM-progenitors of haematopoietic stem cells in vitro. Bioterapy 1996; 9: 171-174.
Dwyer JM. Tranfer factor in the age of molecular biology: a review. Bioterapy 1996; 9: 7-11.
Perez EM, Weisman LE. Nuevos esquemas para la prevención y el tratamiento de la septicemia bacteriana neonatal. Clin Perinatol 1997; 1: 223-240.
Laurence HS, Borkowsky W. Transfer factor current status and future prospects. Bioterapy 1996; 9: 1-5.
Full text